
Is TransMedics (TMDX) stock Halal?
Verdict for TransMedics (TMDX): Shariah compliant (PASS). Screened October 2026 under AAOIFI Shariah Standard No. 21. Business activity: pass. Non-permissible income: pass. Interest-bearing investments: pass. Interest-bearing debt: pass. Preference shares: pass. Dividend purification factor: 98.45%. Next review: November 2026.
TransMedics is a medical technology company focused on the commercialization of organ transplant therapy systems. The company has developed the Organ Care System (OCS), a transformative and portable technology that replicates the conditions of the human body to preserve donor organs for transplantation. This system significantly impacts the organ transplant sector by improving the viability and availability of organs through extended preservation and transport periods. Before any of that matters to a Muslim investor, one question comes first: is TransMedics stock Halal?
Is TransMedics Shariah compliant?
Yes. In the October 2026 screening TransMedics (TMDX) passes AAOIFI Shariah Standard No. 21: the business activity screen and every financial ratio screen hold. Healthcare rarely troubles the activity screen; treating illness is permissible work. For TransMedics, the AAOIFI Shariah Standard No. 21 verdict turns on the balance sheet instead: research is capital hungry, and interest bearing debt and investments must each stay below 30% of market capitalisation.
Does TransMedics pass the business activity test?
Yes. In the October 2026 screening TransMedics holds an overall PASS, which a stock only earns when its core business clears the activity screen. Treating illness is permissible work; the scrutiny belongs to the financing behind it.
Is TransMedics' income Halal?
Yes, within AAOIFI's tolerance. TransMedics' income from non-permissible sources stays below 5% of revenue in the October 2026 screening, and the small impure portion is handled through purification: the factor of 98.45% tells holders of TMDX what share of each dividend to keep and what remainder to donate to charity. On a dividend yield of around None, the purification amount is modest but real.
Does TransMedics meet AAOIFI's debt and investment ratio requirements?
Yes. Both caps hold this month: interest bearing investments and interest bearing debt each stay below 30% of market capitalisation, measured against a market capitalisation of $2.89B (market data as of 1 October 2026). Because the caps move with the share price, our Shariah Supervisory Board has TMDX re-screened every month, and the result above always shows the latest verdict.
Why do other halal screeners show a different verdict for TransMedics?
Screeners can disagree without either being wrong. AAOIFI Shariah Standard No. 21, which Tabadulat applies, measures interest bearing debt and investments against market capitalisation with a 30% ceiling. MSCI and FTSE measure them against total assets with a 33% ceiling, and S&P and Dow Jones Islamic use a multi year average of market capitalisation. Data dates differ too, because each provider reads filings and prices on its own schedule. The same company can therefore pass one standard and fail another in the same month. Tabadulat publishes one answer, the AAOIFI result as of October 2026, and re-screens it every month.
Tabadulat is an ADGM regulated brokerage whose license covers Shari'a Compliant Regulated Activities, as the FSRA permission names them. New to the terminology? Gharar and Maysir, Sukuk, Zakat and purification are all explained in plain English.
New to the screening method? Read What is Halal Investing? A Guide to Halal Stocks and Islamic Finance










